CRISPR Therapeutics AG (CRSP) Prepaid Assets (2015 - 2026)

CRISPR Therapeutics AG (CRSP) has 12 years of Prepaid Assets data on file, last reported at $6.6 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets fell 46.64% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.6 million (down 46.64% YoY), and the FY2025 full-year result was $9.8 million, up 18.5% from the prior year.
• Prepaid Assets fell to $6.6 million in Q1 2026, from $9.8 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $41.7 million in Q2 2022 to a low of $6.6 million in Q1 2026.
• A 5-year average of $19.3 million and a median of $13.4 million in 2025 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets slumped 61.85% in 2023 and soared 62.28% in 2025, its largest moves.
• Tracing CRSP's Prepaid Assets over 5 years: stood at $37.7 million in 2022, then tumbled by 61.85% to $14.4 million in 2023, then plunged by 42.26% to $8.3 million in 2024, then gained by 18.5% to $9.8 million in 2025, then tumbled by 33.18% to $6.6 million in 2026.
• Business Quant data shows CRSP's Prepaid Assets at $6.6 million in Q1 2026, $9.8 million in Q4 2025, and $13.4 million in Q3 2025.